Trademark: 88879373
Word
RESONANCEDX
Status
Dead
Status Code
606
Status Date
Monday, August 14, 2023
Serial Number
88879373
Mark Type
4000
Filing Date
Monday, April 20, 2020
Published for Opposition
Tuesday, November 17, 2020
Abandoned Date
Monday, August 14, 2023

Trademark Owner History
ResonanceDx, Inc. - Owner At Publication

Classifications
10 Medical diagnostic devices for identifying antigens in blood, urine, saliva, serum, cerebral spinal fluid, sweat, and sputum; Medical diagnostic devices, namely, medical diagnostic apparatus for testing for viruses; Medical diagnostic equipment, namely, portable testing instruments in the nature of hand-held and bench-top instruments to test diagnostic cartridges for identifying antigens in blood, urine, saliva, serum, cerebral spinal fluid, sweat, and sputum; Medical diagnostic equipment, namely, portable testing instruments in the nature of hand-held or bench-top instruments to test diagnostic cartridges for identifying antigens in blood, urine, saliva, serum, cerebral spinal fluid, sweat, and sputum; Medical diagnostic system comprised of medical diagnostic bench-top and hand-held instruments, test cartridges, and test sample collection vials used to detect and measure antigens and antibodies; Medical diagnostic system comprised of medical diagnostic bench-top or hand-held instruments, test cartridges, and test sample collection vials used to detect and measure antigens and antibodies; Medical devices, namely, portable diagnostic platforms comprised of medical diagnostic bench-top and hand-held instruments, test cartridges, and test sample collection vials for detecting, measuring and analyzing body fluids and human biological samples; Medical devices, namely, portable diagnostic platforms comprised of medical diagnostic bench-top or hand-held instruments, test cartridges, and test sample collection vials for detecting, measuring and analyzing body fluids and human biological samples; Diagnostic kits comprised of test cartridges and test sample collection vials for use in antigens and antibodies testing for clinical, research, or medical use

Trademark Events
Aug 14, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Aug 14, 2023
Abandonment - No Use Statement Filed
Nov 9, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 7, 2022
Sou Extension 4 Granted
Nov 7, 2022
Sou Extension 4 Filed
Nov 7, 2022
Sou Teas Extension Received
Jun 11, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 9, 2022
Sou Extension 3 Granted
Jun 9, 2022
Sou Extension 3 Filed
Jun 9, 2022
Sou Teas Extension Received
Dec 23, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 21, 2021
Sou Extension 2 Granted
Dec 21, 2021
Sou Extension 2 Filed
Dec 21, 2021
Sou Teas Extension Received
Jun 17, 2021
Notice Of Approval Of Extension Request E-Mailed
Jun 15, 2021
Sou Extension 1 Granted
Jun 15, 2021
Sou Extension 1 Filed
Jun 15, 2021
Sou Teas Extension Received
Jan 12, 2021
Noa E-Mailed - Sou Required From Applicant
Nov 17, 2020
Official Gazette Publication Confirmation E-Mailed
Nov 17, 2020
Published For Opposition
Oct 28, 2020
Notification Of Notice Of Publication E-Mailed
Oct 13, 2020
Approved For Pub - Principal Register
Oct 13, 2020
Examiner's Amendment Entered
Oct 13, 2020
Notification Of Examiners Amendment E-Mailed
Oct 13, 2020
Examiners Amendment E-Mailed
Oct 13, 2020
Examiners Amendment -Written
Oct 5, 2020
Teas/Email Correspondence Entered
Oct 5, 2020
Correspondence Received In Law Office
Oct 3, 2020
Assigned To Lie
Aug 28, 2020
Teas Response To Office Action Received
Jul 17, 2020
Notification Of Non-Final Action E-Mailed
Jul 17, 2020
Non-Final Action E-Mailed
Jul 17, 2020
Non-Final Action Written
Jul 13, 2020
Assigned To Examiner
Apr 29, 2020
New Application Office Supplied Data Entered
Apr 23, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24